| Record ID | ia:optionsforcontro0000inte_d4s2 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/optionsforcontro0000inte_d4s2/optionsforcontro0000inte_d4s2_marc.xml |
| Download MARC binary | https://www.archive.org/download/optionsforcontro0000inte_d4s2/optionsforcontro0000inte_d4s2_meta.mrc |
LEADER: 03690cam 2200745 a 4500
001 ocm56087767
003 OCoLC
005 20200521215659.0
008 040804s2004 ne a b 101 0 eng
040 $aNLM$beng$cNLM$dOS2$dOHX$dUKM$dBAKER$dNLGGC$dYDXCP$dCGC$dBTCTA$dGEBAY$dMMU$dOCLCF$dOCLCO$dOCLCQ$dOCLCO$dOCLCQ$dNLM$dOCLCO$dOCLCA
015 $aGBA442374$2bnb
016 7 $a101228872$2DNLM
016 7 $a012929775$2Uk
020 $a9780444516398
020 $a0444516395
035 $a(OCoLC)56087767
042 $anlmcopyc
050 4 $aRA644.I6$bI58 2003
060 00 $aW3$bEX89 no.1263 2004
060 10 $aWC 515$bI602o 2004
072 7 $aRA$2lcco
082 04 $a614.5'18$222
084 $a44.75$2bcl
111 2 $aInternational Conference on Options for the Control of Influenza$d(2003 :$cOkinawa, Japan)
245 10 $aOptions for the control of influenza V :$bproceedings of the International Conference on Options for the Control of Influenza V, held in Okinawa, Japan, October 7-11, 2003. /$ceditor, Yoshihiro Kawaoka.
250 $a1st ed.
260 $aAmsterdam ;$aSan Diego :$bElsevier,$c©2004.
300 $axxvii, 850 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aInternational congress series,$x0531-5131 ;$vno. 1263
504 $aIncludes bibliographical references and indexes.
505 2 $aImpact -- Immunology -- Structure and function -- Replication -- Antivirals -- Vaccines -- Pathogenesis and interspecies transmission -- Oral presentations -- Epidemiology/diagnosis -- Replication -- Clinical trials, management and policies -- Pathogenesis/virus-cell interactions -- Genetics and evolution -- Animal influenza -- Pandemic and interpandemic planning -- Posters.
650 0 $aInfluenza$vCongresses.
650 0 $aInfluenza vaccines$vCongresses.
650 12 $aInfluenza, Human$xprevention & control.$0https://id.nlm.nih.gov/mesh/D007251Q000517
650 22 $aInfluenza Vaccines.$0https://id.nlm.nih.gov/mesh/D007252
650 22 $aInfluenza, Human$xvirology.$0https://id.nlm.nih.gov/mesh/D007251Q000821
650 7 $aInfluenza.$2fast$0(OCoLC)fst00972493
650 7 $aInfluenza vaccines.$2fast$0(OCoLC)fst00972507
650 7 $aGrippe$2gnd
650 7 $aPrävention$2gnd
650 7 $aKongress$2gnd
650 7 $aGesundheitsvorsorge$2gnd
650 17 $aInfluenza.$2gtt
650 17 $aEpidemiologie.$2gtt
650 17 $aVaccinatie.$2gtt
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
700 1 $aKawaoka, Y.$q(Yoshihiro)
776 08 $iOnline version:$aInternational Conference on Options for the Control of Influenza (2003 : Okinawa, Japan).$tOptions for the control of influenza V.$b1st ed.$dAmsterdam ; San Diego : Elsevier, ©2004$w(OCoLC)607456214
776 08 $iOnline version:$aInternational Conference on Options for the Control of Influenza (2003 : Okinawa, Japan).$tOptions for the control of influenza V.$b1st ed.$dAmsterdam ; San Diego : Elsevier, ©2004$w(OCoLC)607675500
830 0 $aInternational congress series ;$vno. 1263.
938 $aBaker & Taylor$bBKTY$c386.00$d386.00$i0444516395$n0006092007$sactive
938 $aBaker and Taylor$bBTCP$nBK0006092007
938 $aOtto Harrassowitz$bHARR$nhar045017879
938 $aYBP Library Services$bYANK$n2131310
029 0 $aNLM$b101228872
029 1 $aAU@$b000026754502
029 1 $aGEBAY$b7379750
029 1 $aNLGGC$b265115329
029 1 $aYDXCP$b2131310
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 44 OTHER HOLDINGS